title: [We must learn how to be better to evaluate drug benefits and risks].
authors.affiliation: Pfizer. Eva.Dahl@Pfizer.com
authors.forename: Eva
authors.initials: E
authors.lastname: Dahl
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002986:Clinical Trials as Topic / Q000592:standards; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D004341:Drug Evaluation / Q000592:standards; D004345:Drug Industry; D004346:Drug Information Services / Q000592:standards; D006801:Humans; D012307:Risk Factors; D012449:Safety
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors